Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-9701 for gastrointestinal symptoms and quality of life in POTS
KCT0006932Phase 4Completed
- Sponsor
- Dong-A ST
- Start
- Apr 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Motilitone in postural orthostatic tachycardia syndrome (POTS), sponsored by Dong-A ST. Started Apr 2022; status: completed.
02
Drugs
Motilitone
03
Conditions
postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on KCT0006932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006932.